drug

vosoritide

1 story · latest Aug 6, 2026

Status: FDA approved Nov 2021 · NDA214938
Brands: Voxzogo, Voxzogo 0.4mg, Voxzogo 0.56mg, Voxzogo 1.2mg

Relationships

Developed by Biomarin Pharmaceutical Inc

Timeline

BioMarin raises 2026 revenue and VOXZOGO guidance, discontinues BMN 401

Aug 6Quarterly updateBiomarin Pharmaceutical Inc vosoritide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.